FY18
Assets20.52
Net Worth4.21
Total Debt7.22
RevenueAnnualised basis35.43
EBITDAAnnualised basis1.46
PATAnnualised basis0.85
EBITDA Margin (%)4.12
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets27.41₹ Cr · +212.2% vs prior year
Net Worth5.07₹ Cr · +272.8% vs prior year
FY17
Assets11.08
Net Worth1.52
Total Debt2.08
RevenueAnnualised basis23.33
EBITDAAnnualised basis0.31
PATAnnualised basis0.15
EBITDA Margin (%)1.33
FY16
Assets8.78
Net Worth1.36
Total Debt1.89
RevenueAnnualised basis18.56
EBITDAAnnualised basis0.47
PATAnnualised basis0.09
EBITDA Margin (%)2.53
31-Dec-18
Assets27.41
Net Worth5.07
Total Debt7.89
RevenueAnnualised basis34.49
EBITDAAnnualised basis1.92
PATAnnualised basis0.86
IPO UPDATE ALERTS
Register for IPO Updates →Track Earum Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.